| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |